Cdsco
-
{
- All
- News
- Videos
-
42 Drug Samples Found 'Not Of Standard Quality (NSQ)' In April: Health Ministry
According to routine regulatory surveillance, the list of not of standard quality (NSQ) and spurious drugs is displayed on the CDSCO portal every month.
-
Injectable Cosmetic Products Not Permitted, Drug Regulator Issues Warning
Cosmetic products supplied in injectable form do not fall under the definition of cosmetics under the law and are not permitted for use by consumers, professionals or aesthetic clinics, the central drug regulator has made it clear.
-
Drug Regulator Tightens Watch On GLP-1 Weight-Loss Drugs, Issues Notice
The Central Drugs Standard Control Organization, along with state regulators, has initiated targeted enforcement measures to curb malpractices and ensure ethical pharmaceutical practices in the supply chain.
-
India Cracks Down On Ads For Weight-Loss Drugs Like GLP-1 In New Advisory
India's Health Ministry has warned pharmaceutical firms against promoting GLP-1 weight-loss drugs to the public. The CDSCO says direct or indirect advertising, including influencer campaigns, violates drug laws and could attract regulatory action.
-
Central Drugs Body Revamps Testing Permissions To Fast-Track Drug Approvals in India
India's drug regulator Central Drugs Standard Control Organization has revised testing permission norms to speed up approvals. From June 1, 2026, companies can start lab testing immediately after application, a step aimed at reducing delays while mai
-
What Is Imfinzi Durvalumab, The Cancer Drug That Just Got Approval For Use In India?
Unlike traditional chemotherapy, which attacks rapidly dividing cells (both healthy and cancerous), Durvalumab helps your own immune system recognise and destroy cancer cells. It targets a specific protein called PD-L1.
-
Cancer Drug Imfinzi Gets Indian Regulator's Approval For Use In First-Line Treatment
AstraZeneca Pharma India Limited on Tuesday said it has received permission from the Central Drugs Standard Control Organisation to sell and distribute Durvalumab solution for infusion used in cancer treatment.
-
17,990 Jan Aushadhi Kendras Opened Across India Till December 31, Says JP Nadda
A total of 17,990 Jan Aushadhi Kendras (JAKs) have been opened across the country till December 31, Union Health Minister JP Nadda informed the Parliament on Friday.
-
Indian Drug Regulators Flag 167 Medicines As Unsafe In December 2025
The Central Drugs Standard Control Organisation (CDSCO) on Wednesday declared 167 drug samples tested by the Central and state drugs regulatory authorities as not of standard quality (NSQ)' in its monthly drug alert for Dece
-
India To Become Global Innovation-Led Pharma Giant In 5 Years: Central Drugs Body Says
India is well positioned to evolve from being the pharmacy of the world to an innovation-led pharma nation over the next five years, said Dr. R Chandrashekar, Joint Drugs Controller, the Central Drugs Standard Control Organization (CDSCO).
-
Central Drug Regulator Blames Tamil Nadu Lapses For Syrup Tragedy: Sources
The central drug regulator has blamed the negligence of Tamil Nadu authorities for the cough syrup tragedy.
-
Centre Flags Carcinogen Fears On Acidity Medicine Ranitidine, Orders Probe
The Central Drugs Standard Control Organisation (CDSCO) has directed all state and union territory drug regulators to ensure manufacturers of Ranitidine -- a commonly used acidity medicine --monitor NDMA levels.
-
India Proposes Training Programmes For Foreign Drug Regulators
India is likely to provide practical insights to certain countries on the best practices in drug regulations and the impactful initiatives taken by the Indian drug regulators, officials said on Wednesday.
-
'Once-A-Week Shot' Weight-Loss Drug Mounjaro Launched In India By Eli Lilly
Eli Lilly and Company (India) on Thursday said it has launched a first-of-its-kind medication for obesity and type 2 diabetes in the country after obtaining approval from the Central Drugs Standard Control Organisation (CDSCO).
-
Paracetamol, 50 Other Drug Samples Fail Quality Test. See Full List
Popular medications like paracetamol, pantoprazole and various antibiotics failed quality tests.
![[Sponsored] 5 Reasons Why the Samsung Galaxy Watch6 Classic is the Only Smartwatch You Need](https://c.ndtvimg.com/2025-06/j3n52ipk_samsung-galaxy-watch6-classic_160x120_26_June_25.jpg?downsize=245:163 "[Sponsored] 5 Reasons Why the Samsung Galaxy Watch6 Classic is the Only Smartwatch You Need")
-
42 Drug Samples Found 'Not Of Standard Quality (NSQ)' In April: Health Ministry
According to routine regulatory surveillance, the list of not of standard quality (NSQ) and spurious drugs is displayed on the CDSCO portal every month.
-
Injectable Cosmetic Products Not Permitted, Drug Regulator Issues Warning
Cosmetic products supplied in injectable form do not fall under the definition of cosmetics under the law and are not permitted for use by consumers, professionals or aesthetic clinics, the central drug regulator has made it clear.
-
Drug Regulator Tightens Watch On GLP-1 Weight-Loss Drugs, Issues Notice
The Central Drugs Standard Control Organization, along with state regulators, has initiated targeted enforcement measures to curb malpractices and ensure ethical pharmaceutical practices in the supply chain.
-
India Cracks Down On Ads For Weight-Loss Drugs Like GLP-1 In New Advisory
India's Health Ministry has warned pharmaceutical firms against promoting GLP-1 weight-loss drugs to the public. The CDSCO says direct or indirect advertising, including influencer campaigns, violates drug laws and could attract regulatory action.
-
Central Drugs Body Revamps Testing Permissions To Fast-Track Drug Approvals in India
India's drug regulator Central Drugs Standard Control Organization has revised testing permission norms to speed up approvals. From June 1, 2026, companies can start lab testing immediately after application, a step aimed at reducing delays while mai
-
What Is Imfinzi Durvalumab, The Cancer Drug That Just Got Approval For Use In India?
Unlike traditional chemotherapy, which attacks rapidly dividing cells (both healthy and cancerous), Durvalumab helps your own immune system recognise and destroy cancer cells. It targets a specific protein called PD-L1.
-
Cancer Drug Imfinzi Gets Indian Regulator's Approval For Use In First-Line Treatment
AstraZeneca Pharma India Limited on Tuesday said it has received permission from the Central Drugs Standard Control Organisation to sell and distribute Durvalumab solution for infusion used in cancer treatment.
-
17,990 Jan Aushadhi Kendras Opened Across India Till December 31, Says JP Nadda
A total of 17,990 Jan Aushadhi Kendras (JAKs) have been opened across the country till December 31, Union Health Minister JP Nadda informed the Parliament on Friday.
-
Indian Drug Regulators Flag 167 Medicines As Unsafe In December 2025
The Central Drugs Standard Control Organisation (CDSCO) on Wednesday declared 167 drug samples tested by the Central and state drugs regulatory authorities as not of standard quality (NSQ)' in its monthly drug alert for Dece
-
India To Become Global Innovation-Led Pharma Giant In 5 Years: Central Drugs Body Says
India is well positioned to evolve from being the pharmacy of the world to an innovation-led pharma nation over the next five years, said Dr. R Chandrashekar, Joint Drugs Controller, the Central Drugs Standard Control Organization (CDSCO).
-
Central Drug Regulator Blames Tamil Nadu Lapses For Syrup Tragedy: Sources
The central drug regulator has blamed the negligence of Tamil Nadu authorities for the cough syrup tragedy.
-
Centre Flags Carcinogen Fears On Acidity Medicine Ranitidine, Orders Probe
The Central Drugs Standard Control Organisation (CDSCO) has directed all state and union territory drug regulators to ensure manufacturers of Ranitidine -- a commonly used acidity medicine --monitor NDMA levels.
-
India Proposes Training Programmes For Foreign Drug Regulators
India is likely to provide practical insights to certain countries on the best practices in drug regulations and the impactful initiatives taken by the Indian drug regulators, officials said on Wednesday.
-
'Once-A-Week Shot' Weight-Loss Drug Mounjaro Launched In India By Eli Lilly
Eli Lilly and Company (India) on Thursday said it has launched a first-of-its-kind medication for obesity and type 2 diabetes in the country after obtaining approval from the Central Drugs Standard Control Organisation (CDSCO).
-
Paracetamol, 50 Other Drug Samples Fail Quality Test. See Full List
Popular medications like paracetamol, pantoprazole and various antibiotics failed quality tests.
